Company / Cash & Equivalents
Medline Inc. Cash & Equivalents History
FY2024-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Cash & Equivalents
$1.9B
FY2025
5-year range
$199.0M / $1.9B
FY2024-FY2025
Trend
+874.4%
vs FY2024
Sector context
#23 of 148
Health Care
What the data says
Medline Inc.'s cash & equivalents of $1.9B is higher than 84% of companies in the Health Care sector (FY2025).
Based on SEC 10-K filings.
$1.9B in FY2025. Top quartile in the Health Care sector.
Health Care sector context is included.
Cash & Equivalents over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Top 16% in Health CareTop 16% of 148This company $1.9B Sector average $1.2B
▼
+64.8% above sector average
Key checks
Key Insights
- In FY2025, cash & equivalents increased 874.4% year-over-year.
- Ranks #23 out of 148 companies in the Health Care sector.
Annual data
| Year | Cash & EquivalentsValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $1.9B | +874.4% |
| FY2024 | $199.0M | - |
| FY2023 | - | - |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026